Specialty Urology

• Featured

  Orthotopic Neobladder Reconstruction Restores Quality of Life for Female Cystectomy Patients

  Orthotopic neobladder reconstruction is becoming the diversion procedure of choice for female cystectomy patients due to recent advances in care for female urology patients.

  Bladder, Urology

  Article September 24, 2018

• Featured

  Multiparametric MRI/Ultrasound Fusion Biopsy Improves Prostate Cancer Detection

  Active surveillance (AS) has become an accepted way to manage prostate cancer in men at lower risk. Multiparametric MRI can be used in conjunction with the standard transrectal ultrasound (TRUS)-guided biopsy to improve detection of clinically significant cancers.

  Prostate, Urology

  Article September 5, 2018

• Featured

  Improving the Safety of Vena Caval Thrombectomy in Kidney Cancer with Tumor Thrombus Team Approach

  Complete removal of a tumor thrombus resulting from venous tumor invasion is essential for eliminating the cancer in patients with advanced renal cell carcinoma (RCC). A multispecialty tumor thrombus team within an integrated practice can improve the safety of this intricate and extensive procedure.

  Kidney, Urology

  Article September 21, 2018

• Review: Molecular Biomarkers May Lead to Personalized Treatment of Muscle-invasive Bladder Cancer

  Rapidly emerging molecular biomarkers will allow oncologists to choose more confidently between radical cystectomy and trimodality therapy for patients with muscle-invasive bladder cancer, as well as identify which patients undergoing trimodality therapy are likely to benefit from adding immunotherapy.

  Bladder, Urology

  Journal April 19, 2019

• Improving Cost-effectiveness of Second-line Pembrolizumab for Advanced Urothelial Carcinoma

  Among patients with advanced urothelial carcinoma who need second-line therapy, reserving pembrolizumab for those whose tumors express PD-L1 may improve cost-effectiveness, according to computer modeling studies at Massachusetts General Hospital.

  Urology

  Journal April 12, 2019

• New Target Discovered for Prostate Cancer Immunotherapy

  Genitourinary pathologists at Massachusetts General Hospital are the first to demonstrate that PD-L1 expression is highly prevalent in prostate tumor-associated nerves. Such nerves may represent an important target for immunotherapy regimens.

  Prostate, Urology

  Journal April 1, 2019

View all Urology Updates